Magellan Health to Participate in Bernstein Healthcare Services Disruptors Conference
Get Alerts MGLN Hot Sheet
Join SI Premium – FREE
SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) today announced that Mostafa Kamal, chief executive officer of Magellan Rx Management and Sam Srivastava, chief executive officer of Magellan Healthcare, will participate in a fireside chat at the Bernstein Healthcare Services Disruptors Conference in Boston on Tuesday, November 14, 2017 at 12:30 p.m. Eastern.
About Magellan Health: Magellan Health, Inc. is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. For more information, visit MagellanHealth.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171023005162/en/
Magellan Health, Inc.
Media Contact:
Colleen Flanagan
Johnson, 860-507-1923
[email protected]
or
Investor
Contact:
Joe Bogdan, 860-507-1910
[email protected]
Source: Magellan Health, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Glucose Health, Inc. (OTCID: GLUC) Appoints Consumer Products Industry Veteran John Duffy as Chief Executive Officer to Accelerate Growth, Elevate Brand Leadership, and Maximize Long-Term Shareholder
- vAuto Launches Test Drive, New Initiative to Scale and Speed Product Innovations
- Lobe Sciences Expands Leadership Team with New CFO Appointment
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Sanford C. BernsteinSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share